677 related articles for article (PubMed ID: 19200271)
1. Optimal management of chronic heart failure in patients with chronic kidney disease.
Zachariah D; Kalra PA; Kalra PR
J Ren Care; 2009 Mar; 35(1):2-10. PubMed ID: 19200271
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological treatment of chronic heart failure in patients with renal failure].
Stawicki S; Starczewska MH; Roik M; Opolski G
Kardiol Pol; 2005 Mar; 62(3):254-60. PubMed ID: 15830021
[No Abstract] [Full Text] [Related]
3. Potential novel pharmacological therapies for myocardial remodelling.
Landmesser U; Wollert KC; Drexler H
Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
[TBL] [Abstract][Full Text] [Related]
4. The HF epidemic: the need for new treatment strategies.
Carson PE
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S32-4. PubMed ID: 17199218
[TBL] [Abstract][Full Text] [Related]
5. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
Belenkov IuN; Mareev VIu; Skvortsov AA
Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
[No Abstract] [Full Text] [Related]
6. [Management of advanced chronic heart failure].
Oliva F; Macera F; Verde A; Frigerio M
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):112S-117S. PubMed ID: 19195318
[TBL] [Abstract][Full Text] [Related]
7. Broken pump or leaky filter? Renal dysfunction in heart failure a contemporary review.
Petrie CJ; Mark PB; Weir RA
Int J Cardiol; 2008 Aug; 128(2):154-65. PubMed ID: 18191240
[TBL] [Abstract][Full Text] [Related]
8. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
Dulin BR; Krum H
Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of heart failure and preserved systolic function].
Dahlström U; Boman K; Brodin LA; Hagerman I; Willenheimer R
Lakartidningen; 2007 Aug 22-28; 104(34):2348-50. PubMed ID: 17907560
[No Abstract] [Full Text] [Related]
10. [The defibrillator is not a comprehensive healing method].
Stiefelhagen P
MMW Fortschr Med; 2006 Aug; 148(31-32):14. PubMed ID: 16938917
[No Abstract] [Full Text] [Related]
11. [Recent advances and limitations of medical treatment on heart failure].
Momomura S
Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
[TBL] [Abstract][Full Text] [Related]
12. The incidence and implications of aldosterone breakthrough.
Bomback AS; Klemmer PJ
Nat Clin Pract Nephrol; 2007 Sep; 3(9):486-92. PubMed ID: 17717561
[TBL] [Abstract][Full Text] [Related]
13. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS
Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
[TBL] [Abstract][Full Text] [Related]
14. Neurohormones and heart failure: the importance of aldosterone.
Odedra K; Ferro A
Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
[TBL] [Abstract][Full Text] [Related]
15. [Chronic heart failure--the epidemic of the 21st century].
Czuriga I
Orv Hetil; 2005 May; 146(20 Suppl 2):1075-87. PubMed ID: 15945236
[TBL] [Abstract][Full Text] [Related]
16. Neurohormonal antagonism in heart failure: what is the optimal strategy?
Sackner-Bernstein JD; Hart D
Mt Sinai J Med; 2004 Mar; 71(2):115-26. PubMed ID: 15029403
[TBL] [Abstract][Full Text] [Related]
17. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
O'Connor CM; Arumugham P
Clin Geriatr Med; 2007 Feb; 23(1):141-53. PubMed ID: 17126759
[TBL] [Abstract][Full Text] [Related]
18. [Chronic heart failure treatment in the year 2006].
De Berrazueta Fernández JR
An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological therapy of chronic heart failure in the elderly].
Sabbadini G; Di Lenarda A; Metra M; Nodari S; Moretti M; Brentana L; Dei Cas L; Sinagra G
Ital Heart J; 2004 Dec; 5 Suppl 10():37S-51S. PubMed ID: 15712511
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation.
Morath C; Schmied B; Mehrabi A; Weitz J; Schmidt J; Werner J; Buchler MW; Morcos M; Nawroth PP; Schwenger V; Doehler B; Opelz G; Zeier M
Clin Transplant; 2009 Dec; 23 Suppl 21():33-6. PubMed ID: 19930314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
